Attenuation of Atherosclerosis with PAR4 Deficiency: Differential Platelet Outcomes in apoE-/- vs. Ldlr-/- Mice

Caris A. Wadding-Lee, Megan Jay, Shannon M. Jones, Joel Thompson, Deborah A. Howatt, Alan Daugherty, Nigel Mackman, A. Phillip Owens
{"title":"Attenuation of Atherosclerosis with PAR4 Deficiency: Differential Platelet Outcomes in apoE-/- vs. Ldlr-/- Mice","authors":"Caris A. Wadding-Lee, Megan Jay, Shannon M. Jones, Joel Thompson, Deborah A. Howatt, Alan Daugherty, Nigel Mackman, A. Phillip Owens","doi":"10.1101/2024.08.01.606266","DOIUrl":null,"url":null,"abstract":"<strong>Objective</strong> Cardiovascular disease (CVD) is a significant burden globally and, despite current therapeutics, remains the leading cause of death. Platelet inhibitors are of interest in CVD treatment to reduce thrombus formation post-plaque rupture as well their contribution to inflammation throughout the progression of atherosclerosis. Protease activated receptor 4 (PAR4) is a receptor highly expressed by platelets, strongly activated by thrombin, and plays a vital role in platelet activation and aggregation. However, the role of PAR4","PeriodicalId":501471,"journal":{"name":"bioRxiv - Pathology","volume":"198 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"bioRxiv - Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.08.01.606266","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective Cardiovascular disease (CVD) is a significant burden globally and, despite current therapeutics, remains the leading cause of death. Platelet inhibitors are of interest in CVD treatment to reduce thrombus formation post-plaque rupture as well their contribution to inflammation throughout the progression of atherosclerosis. Protease activated receptor 4 (PAR4) is a receptor highly expressed by platelets, strongly activated by thrombin, and plays a vital role in platelet activation and aggregation. However, the role of PAR4
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
PAR4 缺陷可减轻动脉粥样硬化:apoE-/-与Ldlr-/-小鼠血小板结果的差异
心血管疾病(CVD)是全球的一个重大负担,尽管目前有各种治疗方法,但仍是导致死亡的主要原因。血小板抑制剂是治疗心血管疾病的重要药物,可减少斑块破裂后血栓的形成,并在动脉粥样硬化的整个过程中减少炎症的发生。蛋白酶激活受体 4(PAR4)是血小板高度表达的受体,被凝血酶强烈激活,在血小板活化和聚集过程中发挥着重要作用。然而,PAR4
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Identification of SPP1-positive macrophages by single-cell spatial analysis in human lung tissues with mycobacterial infection Endothelial miR-34a deletion guards against aneurysm development despite endothelial dysfunction Machine-learning convergent melanocytic morphology despite noisy archival slides Multifocal cutaneous neoplastic vascular proliferations in a rainbow boa (Epicrates cenchria) collection with boid inclusion body disease Growth Analysis of Trichomonas vaginalis in Different Culture Media: Leveraging Large Language Models (LLMs) to Predict and Optimize In Vitro Growth Conditions
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1